4293 articles
The latest software upgrade for Heidelberg’s Anterion anterior segment platform is designed to deepen diagnostic insights and transform surgery planning, said Ophthalmic Instrument Company’s Tim Way.
A University of Otago study has found New Zealand’s growing shortage of ophthalmologists could be compensated for by a “rational division of labour” with optometrists.
Calling all budding dry-eye specialists! The University of Auckland is running a special FREE event to upgrade your dry-eye knowledge and management strategy on Thursday 20 July
Inspired by luxury wristwatches, writing instruments and other precious heirlooms handed down from generation to generation, Switzerland’s Akoni Eyewear’s collection incorporates the latest advances in materials, craftsmanship and technology to reinforce the brand’s intelligent luxury DNA. Utilising
Touching down on New Zealand soil for the first time at the RANZCO NZ 2023 meeting in Wellington, the new Oculus Pentacam AXL Wave took pride of place at the centre of Designs for Vision’s (DFV’s) stand.
A Korean study published in the European Journal of Neurology has found visual disability in age-related macular degeneration (AMD) was associated with the development of Parkinson’s disease (PD). Led
The Centre for Ocular Research & Education (CORE) has dedicated issue 72 of Contact Lens Update to better understanding the underlying causes and treatment advancements for the successful management
Optos has expanded its Optomap ultra-widefield (UWF) retinal imaging modalities for its California device, offering the first UWF red/green/blue (RGB) colour image.
What if your patient could improve their vision in just 15 minutes? That’s the promise of Auckland Eye’s new SMILE Pro laser – a major step forward in eyecare technology.
The Tear Film & Ocular Surface Society (TFOS) is asking optometry practice owners what their current diagnosis and management approaches to dry eye are in a second survey linked to the TFOS dry eye
iPredict, an automated artificial intelligence (AI) retinal screening system, has received CE certification and Australian approval for early detection of age-related macular degeneration (AMD),
US researchers have found that experimental drug 32-134D, previously shown to slow liver tumour growth in mice, could halt proliferative diabetic retinopathy (PDR) and diabetic macular oedema (DMO) in